Product Information
BROMFENAC SODIUM 0.07% EYE DRP is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $12.9679 per ML under NDC 68180043302. Its NADAC has been published 115 times since Apr 17, 2024.
Strength
.805 mg/mL
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180043302
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Last Updated
6/17/2026
Active Ingredients
BROMFENAC SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA206027On Market Since
1/8/2024
Pharmacological Classes
Price Statistics
The NADAC for BROMFENAC SODIUM 0.07% EYE DRP has been published 115 times since Apr 17, 2024, and over the history we have for it it has declined 76.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $12.9679 per ML |
|---|---|
| All-time high | $75.5251 (Jul 10, 2024) |
| All-time low | $11.7673 (Apr 22, 2026) |
| 52-week high | $16.5479 |
| 52-week low | $11.7673 |
| Median price | $16.2892 |
| Average price | $26.2242 |
| Largest weekly change | -53.9% (Nov 20, 2024) |
| Weeks tracked | 115 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the bromfenac sodium market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of BROMFENAC SODIUM 0.07% EYE DRP?
The current National Average Drug Acquisition Cost (NADAC) for BROMFENAC SODIUM 0.07% EYE DRP, manufactured by Lupin Pharmaceuticals Inc., is $12.9679 per ML (NDC 68180043302), effective Jun 24, 2026.
How has the price of BROMFENAC SODIUM 0.07% EYE DRP changed over time?
Over the history we have for it, the NADAC for BROMFENAC SODIUM 0.07% EYE DRP has declined 76.1%. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for BROMFENAC SODIUM 0.07% EYE DRP?
Since Apr 17, 2024, the NADAC for BROMFENAC SODIUM 0.07% EYE DRP has ranged from a low of $11.7673 (Apr 22, 2026) to a high of $75.5251 (Jul 10, 2024), with a median of $16.2892 per ML.
Are there cheaper alternatives to BROMFENAC SODIUM 0.07% EYE DRP?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of BROMFENAC SODIUM 0.07% EYE DRP, so no direct lower-cost alternative is listed.
Who manufactures BROMFENAC SODIUM 0.07% EYE DRP?
BROMFENAC SODIUM 0.07% EYE DRP (NDC 68180043302) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification